Stimulation for treating sleep disordered breathing
Summary
Inspire Medical Systems continuation of US10898709, covering enhanced device architecture and stimulation protocol embodiments for upper airway stimulation therapy. Extends claims across additional stimulation modes, electrode configurations, and therapy delivery methods for the hypoglossal nerve stimulation platform. Inventors: Quan Ni, John Rondoni, David Dieken, Darrell Wagner. Also named in the Inspire v. Nyxoah litigation.
Why it matters
US11806526 as continuation of US10898709 broadens Inspire's core patent position on HNS for sleep apnea. The parallel litigation across parent and continuation reflects Inspire's strategy of layered continuation claims — a standard approach for medical device companies protecting billion-dollar product franchises.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial